Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Mar;10(3):514-7.
doi: 10.3201/eid1003.030252.

Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes

Werner C Albrich  1 , Dominique L Monnet, Stephan Harbarth
Affiliations

Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes

Werner C Albrich et al. Emerg Infect Dis. 2004 Mar.

Abstract

We correlated outpatient antibiotic use with prevalence of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP), macrolide-resistant S. pneumoniae (MRSP), and macrolide-resistant S. pyogenes (MRGAS) in 20 countries. Total antibiotic use was correlated with PNSP (r = 0.75; p < 0.001), as was macrolide use with MRSP (r = 0.88; p < 0.001) and MRGAS (r = 0.71; p = 0.004). Streptococcal resistance is directly associated with antibiotic selection pressure on a national level.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Total antibiotic use in the outpatient setting (vertical axis) versus prevalence of penicillin-nonsusceptible Streptococcus pneumoniae (horizontal axis) in 20 industrialized countries. A regression line was fitted with 95% confidence bands (r = 0.75; p < 0.001).
Figure 2
Figure 2
A. Relationship between macrolide use in the outpatient setting (horizontal axis) and prevalence of macrolide-resistant Streptococcus pneumoniae (vertical axis) in 16 industrialized countries. A regression line was fitted with 95% confidence bands (r = 0.88; p < 0.001). B. Relationship between macrolide use in the outpatient setting (horizontal axis) and prevalence of macrolide-resistant S. pyogenes (vertical axis) in 14 industrialized countries. A regression line was fitted with 95% confidence bands (r = 0.71; p = 0.004).
See this image and copyright information in PMC

References

    1. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003;36(Suppl 1):S11–23. 10.1086/344654 - DOI - PubMed
    1. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983;5:1033–48. - PubMed
    1. Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis. 2001;33:1462–8. 10.1086/322677 - DOI - PubMed
    1. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 1997;337:441–6. 10.1056/NEJM199708143370701 - DOI - PubMed
    1. Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis. 2001;1:251–61. 10.1016/S1473-3099(01)00120-7 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources